Werkgroep Cardiologische centra Nederland English

AFFIRM-AHF (Includerend)

A randomised, double-blind placebo controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron deficient patients admitted for acute heart failure (AFFIRM-AHF)
Middel
ferric carboxymaltose
Populatie
hartfalen
Fase
IV
Jaar aanvang
2016
Meer informatie
ClinicalTrials.gov